MULTI-LINK ULTRA 1003382-28Recalls & reported problems
Abbott Vascular Inc. · MULTI-LINK RX ULTRA Coronary Stent System 5.00 mm x 28 mm · Class 3 · Implant
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08717648035326), received between Apr 18, 2017 and Nov 19, 2018 — classified as 2 injuries, 1 malfunction.
The most frequently reported specific device problem is “Deflation Problem” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Deflation Problem1
- Device Dislodged or Dislocated1
Patient problems
- Angina1
- Dyspnea1
- No Consequences Or Impact To Patient1
- No Patient Involvement1
- Stenosis1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionNov 19, 2018Device Dislodged or Dislocated; Device Dislodged or Dislocated
IT WAS REPORTED THAT DURING REMOVAL OF THE PROTECTIVE SHEATH, WITHOUT RESISTANCE, THE 5.0X28 MM ULTRA STENT DISLODGED INSIDE THE PROTECTIVE SHEATH. THE DEVICE WAS NOT USED. A SAME SIZE ULTRA STENT DELIVERY SYSTEM WAS USED TO COMPLETE THE PROCEDURE. THERE WAS NO REPORTED PATIENT INVOLVEMENT OR A CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Patient Involvement
MAUDE report 8087009 ↗InjuryApr 27, 2018Adverse Event Without Identified Device or Use Problem
THE FOLLOWING WAS REPORTED VIA VOLUNTARY MEDWATCH REPORT (MW5076123): REPORTER STATED SHE HAD A HEART ATTACK IN 2016. SHE STARTED OFF WITH A CARDIO REHAB AND INSTEAD OF FEELING BETTER, FELT WORST. SHE HAD SHORTNESS OF BREATH AND WENT TO THE HOSPITAL. AFTER CARDIAC MONITORING, THE DRS DISCOVERED THAT THE STENT WAS 100% BLOCKED. REPORTER CONTINUES TO EXPERIENCE SYMPTOMS OF A HEART ATTACK IN AN ATTEMPT TO CLEAR THE STENT, THE BALLOON BLOCKED IN THE CORONARY ARTERY. THE DRS PUSHED THE BALLOON TO THE TIP OF ARTERY AND PUT A STENT ON EACH SIDE OF THE ARTERY TO HOLD IT IN PLACE. SHE WAS ADMINISTERED EFFIENT TO PREVENT BLOOD CLOTS. REPORTER IS WORRIED AND AFRAID TO TRAVEL OUT OF OR DO ANYTHING FOR FEAR OF DISLOCATING THE DEVICE. REPORTER STATES THAT THE MANUFACTURER (MFR) REFUSES TO TAKE RESPONSIBILITY REGARDING THIS FAULTY DEVICE. THE FOLLOWING ADDITIONAL INFORMATION WAS RECEIVED: IN (B)(6) 2016, THE PATIENT EXPERIENCED A HEART ATTACK AND AN ULTRA STENT WAS IMPLANTED. ON (B)(6) 2016, THE PATIENT EXPERIENCED ANGINA AND SHORTNESS OF BREATH AND WAS HOSPITALIZED. ANGIOGRAPHY REVEALED 100% STENT RESTENOSIS AND PERCUTANEOUS CORONARY INTERVENTION WAS PERFORMED (SEE MEDWATCH #2024168-2016-05135).
Patient problems: Angina; Dyspnea; Stenosis
MAUDE report 7469512 ↗InjuryApr 18, 2017Deflation Problem
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A LESION LOCATED IN THE RIGHT CORONARY ARTERY. THE US RX ULTRA 9-CELL 5.0/28MM STENT WAS SUCCESSFULLY DEPLOYED BUT THE BALLOON WOULD NOT DEFLATE. THE BALLOON HAD TO BE BURST AND THEN REMOVED FROM THE ANATOMY. THERE WAS NO DIFFICULTY DURING REMOVAL OF THE PROTECTIVE SHEATH AND THE DEVICE WAS PREPPED ACCORDING TO THE INSTRUCTIONS FOR USE. THERE WERE NO REPORTED ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6501886 ↗
Other STENT, CORONARY devices
- WALLSTENT® Endoprosthesis H965403130Boston Scientific Corporation · STENT, CORONARY35 reports
- WALLSTENT® Endoprosthesis H965402130Boston Scientific Corporation · STENT, CORONARY23 reports
- Tryton Side Branch Stent T5-2530-191-USTryton Medical, Inc. · Stent, Coronary1 death22 reports
- WALLSTENT® Endoprosthesis H965403330Boston Scientific Corporation · STENT, CORONARY21 reports
- WALLSTENT® Endoprosthesis H965403320Boston Scientific Corporation · STENT, CORONARY10 reports
- WALLSTENT® Endoprosthesis H965403120Boston Scientific Corporation · STENT, CORONARY9 reports
- PALMAZ Balloon Expandable Stent P308Cordis US Corp. · STENT, CORONARY7 reports
- Cobra PzF 170-03-35024Celonova Biosciences, Inc. · Stent, Coronary7 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page